| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.73B | 33.17B | 31.80B | 29.77B | 27.52B | 25.37B |
| Gross Profit | 15.56B | 15.46B | 14.66B | 13.70B | 13.77B | 14.00B |
| EBITDA | 7.23B | 7.70B | 6.74B | 6.83B | 4.99B | 5.60B |
| Net Income | 5.06B | 5.23B | 4.15B | 4.25B | 2.42B | 4.17B |
Balance Sheet | ||||||
| Total Assets | 80.55B | 80.17B | 81.61B | 82.17B | 78.62B | 75.80B |
| Cash, Cash Equivalents and Short-Term Investments | 9.34B | 10.42B | 10.82B | 14.06B | 10.85B | 9.39B |
| Total Debt | 9.41B | 9.99B | 9.88B | 9.68B | 10.42B | 9.05B |
| Total Liabilities | 60.52B | 59.92B | 61.19B | 61.12B | 58.35B | 54.08B |
| Stockholders Equity | 20.02B | 20.26B | 20.42B | 21.05B | 20.27B | 21.73B |
Cash Flow | ||||||
| Free Cash Flow | 5.51B | 5.56B | 6.77B | 4.22B | 5.11B | 4.89B |
| Operating Cash Flow | 6.39B | 6.42B | 7.45B | 4.84B | 5.81B | 5.80B |
| Investing Cash Flow | 2.35B | 797.00M | 1.69B | 752.00M | -3.33B | -5.15B |
| Financing Cash Flow | -7.51B | -5.96B | -8.28B | -2.99B | -1.20B | -557.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | $613.75B | 24.01 | 58.90% | 0.69% | 14.37% | 13.59% | |
76 Outperform | $41.91B | -29.13 | 3.64% | ― | 2.27% | -69.08% | |
75 Outperform | $213.90B | 17.46 | 33.95% | 0.84% | 9.41% | 12.00% | |
75 Outperform | $436.67B | 28.67 | 206.12% | 0.54% | 17.06% | 21.18% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $39.17B | 9.28 | 25.08% | ― | 6.97% | 19.31% | |
62 Neutral | $2.61B | 10.62 | 47.95% | 10.18% | -2.34% | -49.33% |